Research And Markets Research And Markets
0 CHECKOUT

IL-7 Signaling Pathway in Oncology Drug Pipeline Update

  • ID: 1537335
  • August 2016
  • Region: Global
  • Bioseeker
1 of 2

IL-7 signaling pathway mainly activates the JAK/STAT signaling module.

There are today 90 companies plus partners developing 95 IL-7 pathway targeting drugs in 389 developmental projects in cancer. In addition, there is 1 suspended drug and the accumulated number of ceased drugs over the last years amount to another 36 drugs. Il-7 Signaling Pathway In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 85 different targets. All included targets have been cross-referenced for the presence of mutations associated with human cancer. To date 84 out of the 84 studied drug targets so far have been recorded with somatic mutations. The software application lets you narrow in on these mutations and links out to the mutational analysis for each of the drug targets for detailed information. All drugs targets are further categorized on in the software application by 20 classifications of molecular function and with pathway referrals to BioCarta, KEGG, NCI-Nature and NetPath.

Drug Pipeline Update at a Glance

Investigators
Includes more than 90 principal companies plus their collaborators. There READ MORE >

Note: Product cover images may vary from those shown
2 of 2



Delivery Format: Desktop App plus Online Access to Updates (One Year)

Note: Product cover images may vary from those shown
3 of 2
Note: Product cover images may vary from those shown

RELATED PRODUCTS from Db